Masahiro Miyake1, Masaaki Saito2, Kenji Yamashiro3, Tetsuju Sekiryu2, Nagahisa Yoshimura1. 1. Department of Ophthalmology, Kyoto University Graduate School of Medicine, Kyoto, Japan. 2. Department of Ophthalmology, Fukushima Medical University, Fukushima, Japan. 3. Department of Ophthalmology, Kyoto University Graduate School of Medicine, Kyoto, Japan. yamashro@kuhp.kyoto-u.ac.jp.
Abstract
PURPOSE: To evaluate the genotype distribution of a rare age-related macular degeneration (AMD)-susceptibility variant, complement factor H (CFH) R1210C, among a large Japanese cohort with AMD. METHODS: One thousand three hundred and sixty-four Japanese patients with neovascular AMD were evaluated. We screened for CFH R1210C (rs121913059) by genotyping with the Taqman method; the mutation was confirmed by Sanger sequencing. We also searched for this mutation in the human genome variant database, which contains the whole-exome sequencing data for 1208 Japanese individuals. The detailed characteristics of patients with this mutation were reviewed. RESULTS: The mean age of the patients was 74.5 years (standard deviation 8.7); men accounted for 71.8 % of the patients. The CFH R1210C variant was found in only 1 of the 1364 AMD patients, and was heterozygous (minor allele frequency (MAF) = 0.037 %); it was not found in any of the 1208 individuals in the control group (MAF = 0 %). The patient with CFH R1210C was a 70-year-old woman whose main complaint was visual loss in the right eye. Dilated fundus examination, optical coherence tomography, and fluorescein and indocyanine angiography revealed polypoidal choroidal neovasculopathy (PCV), but no drusen in either eye. Despite treatment, her visual acuity had decreased to 1/50 by 6.8 years after her first visit. CONCLUSIONS: The CFH R1210C variant was found to be rare among Japanese patients with AMD. The patient with the mutation did have the PCV subtype, but no drusen formation. Considering their ethnicity-specific nature, such rare variants should be studied by use of next-generation sequencing for each ethnicity.
PURPOSE: To evaluate the genotype distribution of a rare age-related macular degeneration (AMD)-susceptibility variant, complement factor H (CFH) R1210C, among a large Japanese cohort with AMD. METHODS: One thousand three hundred and sixty-four Japanese patients with neovascular AMD were evaluated. We screened for CFHR1210C (rs121913059) by genotyping with the Taqman method; the mutation was confirmed by Sanger sequencing. We also searched for this mutation in the human genome variant database, which contains the whole-exome sequencing data for 1208 Japanese individuals. The detailed characteristics of patients with this mutation were reviewed. RESULTS: The mean age of the patients was 74.5 years (standard deviation 8.7); men accounted for 71.8 % of the patients. The CFHR1210C variant was found in only 1 of the 1364 AMDpatients, and was heterozygous (minor allele frequency (MAF) = 0.037 %); it was not found in any of the 1208 individuals in the control group (MAF = 0 %). The patient with CFHR1210C was a 70-year-old woman whose main complaint was visual loss in the right eye. Dilated fundus examination, optical coherence tomography, and fluorescein and indocyanine angiography revealed polypoidal choroidal neovasculopathy (PCV), but no drusen in either eye. Despite treatment, her visual acuity had decreased to 1/50 by 6.8 years after her first visit. CONCLUSIONS: The CFHR1210C variant was found to be rare among Japanese patients with AMD. The patient with the mutation did have the PCV subtype, but no drusen formation. Considering their ethnicity-specific nature, such rare variants should be studied by use of next-generation sequencing for each ethnicity.
Authors: Ryo Kawasaki; Miho Yasuda; Su Jeong Song; Shih-Jen Chen; Jost B Jonas; Jie Jin Wang; Paul Mitchell; Tien Y Wong Journal: Ophthalmology Date: 2010-01-27 Impact factor: 12.079
Authors: Hannes Helgason; Patrick Sulem; Maheswara R Duvvari; Hongrong Luo; Gudmar Thorleifsson; Hreinn Stefansson; Ingileif Jonsdottir; Gisli Masson; Daniel F Gudbjartsson; G Bragi Walters; Olafur Th Magnusson; Augustine Kong; Thorunn Rafnar; Lambertus A Kiemeney; Frederieke E Schoenmaker-Koller; Ling Zhao; Camiel J F Boon; Yaojun Song; Sascha Fauser; Michelle Pei; Tina Ristau; Shirrina Patel; Sandra Liakopoulos; Johannes P H van de Ven; Carel B Hoyng; Henry Ferreyra; Yaou Duan; Paul S Bernstein; Asbjorg Geirsdottir; Gudleif Helgadottir; Einar Stefansson; Anneke I den Hollander; Kang Zhang; Fridbert Jonasson; Haraldur Sigurdsson; Unnur Thorsteinsdottir; Kari Stefansson Journal: Nat Genet Date: 2013-09-15 Impact factor: 38.330
Authors: Isao Nakata; Kenji Yamashiro; Yumiko Akagi-Kurashige; Masahiro Miyake; Kyoko Kumagai; Akitaka Tsujikawa; Ke Liu; Li Jia Chen; David T L Liu; Timothy Y Y Lai; Yoichi Sakurada; Seigo Yoneyama; Ching-Yu Cheng; Peter Cackett; Ian Y Yeo; Wan Ting Tay; Belinda K Cornes; Eranga N Vithana; Tin Aung; Keitaro Matsuo; Fumihiko Matsuda; Tien-Yin Wong; Hiroyuki Iijima; Chi Pui Pang; Nagahisa Yoshimura Journal: Invest Ophthalmol Vis Sci Date: 2012-09-25 Impact factor: 4.799
Authors: Johanna M Seddon; Robyn Reynolds; Julian Maller; Jesen A Fagerness; Mark J Daly; Bernard Rosner Journal: Invest Ophthalmol Vis Sci Date: 2008-12-30 Impact factor: 4.799
Authors: Soumya Raychaudhuri; Oleg Iartchouk; Kimberly Chin; Perciliz L Tan; Albert K Tai; Stephan Ripke; Sivakumar Gowrisankar; Soumya Vemuri; Kate Montgomery; Yi Yu; Robyn Reynolds; Donald J Zack; Betsy Campochiaro; Peter Campochiaro; Nicholas Katsanis; Mark J Daly; Johanna M Seddon Journal: Nat Genet Date: 2011-10-23 Impact factor: 38.330
Authors: Maartje J Geerlings; Eveline Kersten; Joannes M M Groenewoud; Lars G Fritsche; Carel B Hoyng; Eiko K de Jong; Anneke I den Hollander Journal: Mol Vis Date: 2018-01-27 Impact factor: 2.367